This inventor holds 1 USPTO granted patent. Top assignee: Icahn School of Medicine at Mount Sinai. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Premkumar Reddy: Inventor in Antiviral Research
Introduction
Premkumar Reddy is an inventor associated with the Icahn School of Medicine at Mount Sinai in New York, NY (US). His patent work explores the potential use of rigosertib to address viral infections.
Latest Patents
Reddy is associated with 1 patent: “Use of Rigosertib to Treat RNA Virus Infections.” The patent describes methods for treating an infection caused by a virus, including an RNA virus such as SARS-CoV-2, or a related disease such as COVID-19. The proposed methods involve administering rigosertib, or a composition containing it, to a subject, including a human subject.
Career Highlights
Reddy’s listed patent reflects research into potential therapeutic applications of rigosertib. His work connects drug development with efforts to investigate treatments for RNA virus infections.
Collaborations
Kris White and M. V. Ramana Reddy are identified as Reddy’s coworkers, reflecting a research environment that brings together collaborators in biomedical science.
Conclusion
Premkumar Reddy’s patent on rigosertib highlights his contribution to research exploring potential treatments for RNA virus infections and associated diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile